Aller au contenu principal
Profil bibliographique

Daniel Havas

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

48Publications signalées
545Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Alzheimer's disease research and treatmentsParkinson's Disease Mechanisms and TreatmentsAdvanced Neuroimaging Techniques and ApplicationsAdvanced MRI Techniques and ApplicationsNuclear Receptors and Signaling

Les publications récentes

Accès ouvert 2026 article OpenAlex

Brain Alterations Linked to the MPTP Mouse Model of Parkinson's Disease Uncovered by Diffusion Kurtosis Imaging and Magnetic Resonance Spectroscopy

Ajay Modi, Sheetal Maria, Jana Kučerová, Eva Dražanová et autres

ABSTRACT Aims This study employed diffusion kurtosis imaging (DKI) and proton magnetic resonance spectroscopy ( 1 H‐MRS) on an MPTP‐induced mouse model of Parkinson's disease (PD) to examine microstructural changes linked to neuroinflammation and neurodegeneration. Methods MPTP (20 mg/kg, i.p.) was given …

cz, us, de, pt, gb (code pays fourni par la source)

0 citations CNS Neuroscience & Therapeutics
Accès ouvert 2026 dataset OpenAlex

Locomotor, Sensorimotor and Pain Outcomes after Graded Mid-Thoracic Contusion in Female Sprague Dawley Rats

Johana Bastidas, Linda Jones, Marco Baptista, Jason Wheeler et autres

STUDY PURPOSE: The objective of this study was to develop and characterize a standardized rat thoracic contusion spinal cord injury (SCI) platform using a commercially available injury device and established methodologies. By applying a graded injury model and a comprehensive set of …

us, ca (code pays fourni par la source)

0 citations UC San Diego
2025 article OpenAlex

Microgliosis and aberrant interferon response in Adar Mavs brain are rescued by PKR removal

Valentina Lacovich, Stanislav Stejskal, Kristina Locker Kovačovicova, David Potěšil et autres

Mutations in the human ADAR gene, encoding adenosine deaminase acting on RNA 1 (ADAR1), cause Aicardi-Goutières syndrome 6, which is a severe auto-inflammatory encephalopathy with aberrant interferon (IFN) induction. AdarΔ2-13 null mutant mouse embryos lacking ADAR1 protein die with high levels of …

cz, us (code pays fourni par la source)

0 citations Brain
Accès ouvert 2025 article OpenAlex

Target Validation Studies of PS48, a PDK-1 Allosteric Agonist, for the Treatment of Alzheimer’s Disease Phenotype in APP/PS1 Transgenic Mice

Henry W. Querfurth, Cynthia Ann Lemere, Jason Ciola, Daniel Havas et autres

The Alzheimer's disease (AD)-affected brain is known to be deficient in the utilization of glucose, its main energy substrate, and systemic diabetes is a significant risk factor for AD. In the course of biochemical and molecular investigations into this puzzling relationship, it …

us (code pays fourni par la source)

1 citation International Journal of Molecular Sciences
Accès ouvert 2025 article OpenAlex

Developmental deletion of amyloid precursor protein precludes transcriptional and proteomic responses to brain injury

Valentina Lacovich, Mária E. Čarná, Sebastian J. Novotný, Shanshan Wang et autres

INTRODUCTION: Amyloid precursor protein (APP) undergoes striking changes following traumatic brain injury (TBI). Considering its role in the control of gene expression, we investigated whether APP regulates transcription and translation following TBI. METHODS: We assessed brain morphology (n = 4-9 mice/group), transcriptome …

cz, us, gb (code pays fourni par la source)

1 citation Alzheimer s & Dementia
Accès ouvert 2024 article OpenAlex

Amyloid precursor protein induces reactive astrogliosis

Gretsen Velezmoro Jáuregui, Dragana Vukić, Isaac G. Onyango, Carlos F. Arias et autres

AIM: Astrocytes respond to stressors by acquiring a reactive state characterized by changes in their morphology and function. Molecules underlying reactive astrogliosis, however, remain largely unknown. Given that several studies observed increase in the Amyloid Precursor Protein (APP) in reactive astrocytes, we …

cz, us, si, es, gb, lt, cn (code pays fourni par la source)

10 citations Acta Physiologica
Accès ouvert 2024 article OpenAlex

Swedish Alzheimer’s disease variant perturbs activity of retrograde molecular motors and causes widespread derangement of axonal transport pathways

Monica Feole, Victorio M. Pozo Devoto, Neda Dragišić, Cayetana Arnaiz et autres

Experimental studies in flies, mice, and humans suggest a significant role of impaired axonal transport in the pathogenesis of Alzheimer's disease (AD). The mechanisms underlying these impairments in axonal transport, however, remain poorly understood. Here we report that the Swedish familial AD …

gb, cz, ar, us, si (code pays fourni par la source)

7 citations Journal of Biological Chemistry
Accès ouvert 2023 preprint OpenAlex

Amyloid precursor protein induces reactive astrogliosis

Gretsen Velezmoro Jáuregui, Dragana Vukić, Isaac G. Onyango, Carlos F. Arias et autres

evidence demonstrating that Amyloid Precursor Protein (APP) acts as an essential instigator of reactive astrogliosis. Cell-specific overexpression of APP in cultured astrocytes led to remodelling of the intermediate filament network, enhancement of cytokine production and activation of cellular programs centred around the …

cz, us, si, es, gb, lt, cn (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2023 article OpenAlex

Preclinical characterization and IND‐enabling safety studies for PNT001, an antibody that recognizes cis‐pT231 tau

Kelly Foster, Matteo Manca, Kim F. McClure, Pyry P. Koivula et autres

BACKGROUND: The cis-conformer of tau phosphorylated at threonine-231 (cis-pT231 tau) is hypothesized to contribute to tauopathies. PNT001 is a humanized, monoclonal antibody that recognizes cis-pT231 tau. PNT001 was characterized to assess clinical development readiness. METHODS: Affinity and selectivity were assessed by surface …

us (code pays fourni par la source)

15 citations Alzheimer s & Dementia
Accès ouvert 2023 article OpenAlex

Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD

Tariq Afroz, Elodie Chevalier, Mickaël Audrain, Christopher Dumayne et autres

Effective therapies are urgently needed to safely target TDP-43 pathology as it is closely associated with the onset and development of devastating diseases such as frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) and amyotrophic lateral sclerosis (ALS). In addition, TDP-43 pathology is …

ch, de, us (code pays fourni par la source)

36 citations Neurobiology of Disease

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.